Therefore, we speculate that specific blockades of Tspan5‐induced Notch signalling and EMT may produce significant clinical benefits for HCC patients who have had elevated activities of Tspan5, Notch signalling and EMT in their primary tumours. The gene discussed is TSPAN5; the disease is neoplasm.